Quarterly Report on Commercially Available Kava Products Q4 2025

The Kava Coalition’s newly released Q4 2025 Market Survey shows clear progress in the quality and safety of commercially available kava products, with 73% meeting microbial safety action limits, up from 49% in Q1 2025. Independent testing of 40 products found no detectable heavy metals, pesticides, mycotoxins, or residual solvents, and confirmed the presence of authentic noble kava chemotypes. While the results point to growing adoption of stronger standards, ongoing microbial challenges highlight why continued testing and transparency remain critical. Read the full report to see what’s improving.

AHP Releases Kava Monograph Executive Summary

The American Herbal Pharmacopoeia® (AHP) released its long-anticipated Kava Rhizome & Root monograph in October, marking a watershed moment in the global dialogue on noble kava’s role as a safe, culturally significant, and pro-social beverage. This comprehensive scientific and ethnobotanical review provides regulators, industry leaders, and consumers with a clear framework for understanding both the safety and the benefits of noble kava.

The Executive Summary, released this week, summarizes the conclusions of one of the most comprehensive reviews of Piper methysticum ever published in the English language.

State of Kava Webinar on January 28th

Join the Kava Coalition and guests for a State of Kava update with Douglas La Rose.

Come connect with other coalition members, hear what’s happening across the kava industry, learn about key opportunities and challenges, ask questions, and share your ideas as we kick off 2026 together.

Day: Wednesday, January 28

Time: 4 p.m. PT / 7 p.m. ET

Where: Zoom (RSVP to receive link)

RSVP: info@kavacoalition.org

Visit our website at kavacoalition.org